All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Hims Alternative 2026

Looking for a Hims alternative for GLP-1 therapy in 2026? We compare physician-supervised programs that offer more personalized care and broader...

By Dr. Michael Torres, MD|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. Michael Torres, MD · Reviewed by Dr. David Kim, MD, FACE

Hims Alternative 2026 custom 2026 header image for Provider Comparisons
Custom header image for Hims Alternative 2026, Provider Comparisons, and better treatment decision-making.
In This Article

This article is part of our Provider Comparisons collection. See also: GLP-1 Guides | Peptide Guides

Search and AI answer brief

Practical answer: Hims Alternative 2026

Looking for a Hims alternative for GLP-1 therapy in 2026? We compare physician-supervised programs that offer more personalized care and broader...

Short answer

Looking for a Hims alternative for GLP-1 therapy in 2026? We compare physician-supervised programs that offer more personalized care and broader...

Search intent

This page answers a specific Provider Comparisons question rather than a generic overview.

What to verify

semaglutide, tirzepatide, peptide evidence quality, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Looking for a Hims alternative for GLP-1 therapy in 2026? We compare physician-supervised programs that offer more personalized care and broader treatment options.

Hims is one of the biggest names in telehealth, and their GLP-1 weight loss program benefits from that scale. Reliable shipping, a polished app, and competitive pricing make it an easy first choice for a lot of patients. The platform works.

But scale comes with tradeoffs. When you're one of hundreds of thousands of patients on a platform, the clinical experience can feel transactional. Provider interactions are brief. Dosing follows a standard schedule. And if you want to explore treatments beyond what is on Hims' menu, you're out of luck.

If any of that sounds familiar, here are the Hims alternatives worth considering in 2026.

Why People Look for Hims Alternatives

Hims patients explore other options for reasons that cluster around a few themes:

  • Impersonal clinical experience. The high-volume model means providers are moving through consultations quickly. Patients who need more time, more explanation, or more nuanced care feel underserved.
  • Limited customization. Hims follows standardized protocols that work for the average patient. But GLP-1 therapy isn't one-size-fits-all, and patients whose response doesn't fit the standard model need a provider who will adapt.
  • No peptide therapy options. Patients interested in BPC-157, therapeutic peptides, or combination protocols can't get them through Hims.
  • Dose-dependent pricing. Starting prices are competitive, but costs can increase as patients titrate to higher doses, making the long-term cost higher than initially expected.
  • Want a physician, not just a provider. There's a difference between a quick telehealth consultation and a physician who actually manages your care. Some patients want the latter and are willing to pay for it.

None of this makes Hims a bad program. It makes it a program built for a specific type of patient, and not every patient fits that mold.

Top Hims Alternatives in 2026

1. FormBlends

FormBlends occupies a different position in the market than Hims. Where Hims optimizes for volume and efficiency, FormBlends optimizes for clinical depth. Every patient works with a licensed physician who builds a personalized protocol, monitors response, and adjusts treatment based on individual outcomes. For a complete cost breakdown, see our compare GLP-1 providers.

Top Telehealth GLP-1 Providers Compared Overall Value Score 0 23 46 69 92 92 78 75 70 FormBlends Hims/Hers Ro Calibrate Based on pricing, support, and patient outcomes
Top Telehealth GLP-1 Providers Compared. Based on pricing, support, and patient outcomes.
View data table
Bar chart showing top telehealth glp-1 providers compared: FormBlends (92), Hims/Hers (78), Ro (75), Calibrate (70)
CategoryOverall Value ScoreDetail
FormBlends92From $299/mo, physician-led
Hims/Hers78Consumer brand, varies
Ro75Telehealth platform
Calibrate70Metabolic health focus
Illustration for Hims Alternative 2026

The medication options are also significantly broader. Beyond compounded semaglutide ($199/month) and tirzepatide ($249/month), FormBlends offers peptide therapies like BPC-157 for recovery, gut health, and inflammation. For patients whose health goals go beyond weight loss or who want a more integrated treatment approach, this matters.

Pricing is flat-rate and transparent. There are no dose-dependent price increases, no hidden consult fees, and no contracts. You pay one price and get everything included.

Pros:

  • Direct physician supervision with personalized protocols
  • Broadest formulary including GLP-1s and peptide therapies
  • Flat-rate pricing that doesn't increase with dose
  • No contracts or long-term commitments

Cons:

  • Higher starting price than the cheapest options
  • Smaller platform, less name recognition

2. Ro Body

Ro provides a level of clinical rigor that Hims doesn't match. Lab monitoring is standard, dosing decisions are data-driven, and the in-house pharmacy provides quality control over compounded medications. For patients who felt that Hims' clinical model was too light, Ro offers a more medically serious alternative.

Starting prices are competitive at $149/month, but plan for costs to increase as you move to higher doses. The program isn't available in every state, so check eligibility before investing time in the enrollment process.

Pros:

  • Lab monitoring included in the program
  • In-house pharmacy for quality control
  • Evidence-based dosing adjustments
  • Competitive starting price

Cons:

  • Costs increase at higher doses
  • Limited state availability
  • No peptide therapy options

3. MEDVi

MEDVi offers a middle ground between Hims' high-volume model and the more personalized care of boutique programs. The platform provides physician consultations, compounded GLP-1 medications, and a more focused weight loss experience. For patients who want slightly more clinical attention without a dramatic change, MEDVi is worth evaluating.

Pros:

  • More focused weight loss platform than Hims
  • Physician consultations included
  • Competitive pricing

Cons:

  • Some patients report communication issues
  • Limited peptide therapy options
  • Mixed reviews on customer support

4. Henry Meds

Henry Meds competes directly with Hims on price while keeping the experience even simpler. At $149/month for compounded semaglutide all-in, there are no dose-based price increases and no hidden fees. If you liked Hims' simplicity but not its pricing trajectory, Henry Meds is the leaner alternative.

Pros:

  • $149/month flat rate, no increases
  • No hidden fees
  • Simple enrollment

Cons:

  • Basic clinical oversight
  • No lab monitoring
  • Limited medication options

5. Calibrate

Calibrate wraps GLP-1 therapy in a thorough metabolic health program. If your criticism of Hims is that it treats weight loss as a medication-only problem, Calibrate's approach, which includes nutrition coaching, exercise guidance, sleep improvement, and behavioral support, may resonate. The cost is higher, but the scope is genuinely different.

Pros:

  • Whole-body approach to metabolic health
  • Includes coaching and lifestyle support
  • Strong clinical framework

Cons:

  • Significantly more expensive
  • Not for patients who just want medication
  • Longer commitment typically required

Hims Alternatives Comparison Table

Program Monthly Cost Clinical Depth Medications Peptide Therapy Contracts
FormBlends $199+ High (physician-led) Semaglutide, tirzepatide, peptides Yes None
Ro Body $149+ High (lab-based) Semaglutide, tirzepatide No None
MEDVi $149+ Moderate Semaglutide, tirzepatide No None
Henry Meds $149 Basic Semaglutide No None
Calibrate $150+ High (thorough) Semaglutide, tirzepatide No Varies

Who Should Consider Switching from Hims

Hims works well for patients who want a straightforward, low-friction GLP-1 experience. But certain situations call for something different:

Not sure which GLP-1 is right for you?

Take a 2-minute assessment and get a personalized recommendation after licensed provider review.

Take the Assessment →
  • You want a physician who knows your case. If you feel like you're interacting with a different provider every time and nobody has continuity on your treatment, a program with dedicated physician oversight (like FormBlends) will feel very different.
  • Your results have plateaued. Standard protocols produce results for most patients, but when progress stalls, you need a provider who will think critically about your situation and adjust accordingly. High-volume platforms aren't built for that.
  • You want peptide therapy. If your goals include recovery support, gut health, or inflammation management alongside weight loss, you need a provider with a broader formulary.
  • Pricing has increased beyond your budget. If Hims' dose-dependent pricing has pushed your monthly costs higher than expected, flat-rate alternatives may offer better long-term value.
  • You want more than a prescription. A prescription is the starting point of GLP-1 therapy, not the whole thing. Patients who want active medical management, not just a recurring prescription, should look at more clinically engaged programs.

Frequently Asked Questions

Is Hims a legitimate GLP-1 provider?

Yes. Hims is a publicly traded telehealth company that works with licensed providers and FDA-registered compounding pharmacies. It's a legitimate program. The question isn't whether it's legitimate but whether its high-volume model provides the level of care you need.

Can I switch from Hims to another provider mid-treatment?

Yes. Enroll with your new provider before canceling Hims to avoid a gap in medication. Share your dosing history and any relevant records with your new physician so they can continue your treatment appropriately.

Are there any Hims alternatives that offer peptide therapy?

FormBlends is one of the few telehealth platforms that offers both GLP-1 medications and peptide therapies like BPC-157. Most major competitors, including Ro, Henry Meds, and MEDVi, focus exclusively on GLP-1s.

Will I get better results with a different program?

Results depend on medication, dosing, adherence, and lifestyle factors. What a different program can offer is more personalized dosing, closer monitoring, and adjustments when your standard protocol isn't producing results. That clinical attention can make a meaningful difference for patients who have plateaued.

Is Hims cheaper than the alternatives?

Hims' starting prices are competitive, but costs can increase at higher doses. Flat-rate programs like Henry Meds ($149/month) and FormBlends ($199/month) may be cheaper at maintenance doses depending on your Hims pricing tier.

Key Points

Hims built its GLP-1 program for scale, and that approach works well for patients who need a reliable, low-touch experience. But if you want more clinical engagement, broader treatment options, or pricing that stays flat as you titrate, the 2026 market has alternatives that deliver on those needs.

Looking for physician-supervised GLP-1 and peptide therapy? FormBlends offers personalized protocols, transparent pricing, and the kind of clinical depth that high-volume platforms can't match. Start your consultation today.

Talk to a licensed provider

Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.

Start the assessment →

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Calibrate official source
Official source
Henry Meds official source
Official source
Hers official source
Official source
Hims official source
Official source
MEDVi official source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Hims Alternative 2026, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Comparison decision path

Use this comparison to narrow the provider review question

Direct answer

Hims Alternative 2026 should help you decide which option deserves a clinical review, not force a one-size answer.

Evidence check

A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.

Safety check

The right choice can change based on history, medication interactions, side effects, budget, and availability.

Next step

After comparing, use the get-started flow to route your goals and health history into the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Looking for a Hims alternative for GLP-1 therapy in 2026? We compare physician-supervised programs that offer more personalized care and broader treatment options. Treat "Hims Alternative 2026" as a way to pressure-test a decision before money, medication, or provider access is involved. The article ties the main claim, safety boundary, and next practical step back to comparison and decision support. It belongs in a comparison page where the details that matter most are access, cost, clinical fit, and what a licensed clinician should confirm. Because this article has 6 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. Keep the final call tied to your own labs, history, medications, and clinician guidance.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Hims Alternative 2026

For this provider comparisons page, the 2026 refresh focuses on semaglutide, tirzepatide, BPC-157, cash-pay pricing, safety signals, hims so the article stays close to the question behind "Hims Alternative 2026".

The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate Hims Alternative 2026 from nearby GLP-1, peptide, hormone, or provider-comparison searches.

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.

Hims Alternative 2026 custom 2026 image for provider comparisons on FormBlends

Custom 2026 image for Hims Alternative 2026, provider comparisons, and better treatment decision-making.

Image description: Unique image for this page covering Hims Alternative 2026, provider comparisons, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Disclosure: FormBlends is one of the providers discussed in this article. Our editorial team independently researches and verifies all pricing and claims. Pricing was last verified in March 2026. Read our editorial policy.

Written by Dr. Michael Torres, MD

Endocrinologist. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.